HER2-positive breast cancer

Drug Cocktail Offers Small Improvement To Breast Cancer Patients

by

A major clinical trial using a new anti-cancer medicine cocktail by the Swiss pharmaceutical giant Roche produced only a modest gain in survival, researchers said Monday. The study added pertuzumab (Perjeta) to the standard therapy, trastuzumab (Herceptin), in 4,805 women with HER2 positive breast cancer, an aggressive illness. “At an early follow up of three … Read more

Elephants Almost Never Get Cancer

by

“Anti-aging medicine is not about stretching out the last years of life. It’s about stretching out the middle years of life… and actually compressing those last year’s few years of life so that diseases of aging happen very, very late in the life cycle, just before death, or don’t happen at all.” — Dr. Klatz. … Read more